+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Luminex Corp (LMNX) - Product Pipeline Analysis, 2021 Update

FEATURED COMPANIES

  • ACEA Biosciences Inc
  • Becton Dickinson and Co
  • Cepheid Inc
  • Hologic Inc
  • Meridian Bioscience Inc
  • Quanterix Corp
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Luminex Corp (Luminex) develops, manufactures and markets proprietary biological testing technologies. The company offers a wide range of products including assays, instruments, reagents and accessories, software and replacement parts. It employs proprietary technologies to test for proteins and nucleic acids, and to serve multiplexing, precision, sensitivity, accuracy, and for reduction of labor. Luminex offers its products to various markets such as pharmaceutical drug discovery; clinical diagnostics; biomedical research including personalized medicine and genomic research. The company sells its products through a direct sales channel and strategic distribution partners in Asia-Pacific North America and Europe. Luminex is headquartered in Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and helps to create effective counter strategies to gain a competitive advantage.

Scope
  • The report reviews the detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Luminex Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides a detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ACEA Biosciences Inc
  • Becton Dickinson and Co
  • Cepheid Inc
  • Hologic Inc
  • Meridian Bioscience Inc
  • Quanterix Corp
Luminex Corp Company Overview
  • Luminex Corp Company Snapshot
  • Luminex Corp Pipeline Products and Ongoing Clinical Trials Overview
  • Luminex Corp - Pipeline Analysis Overview
  • Business Description
  • Luminex Corp - Key Facts
  • Luminex Corp - Major Products and Services
  • Luminex Corp Pipeline Products by Development Stage
  • Luminex Corp Ongoing Clinical Trials by Trial Status
Luminex Corp Pipeline Products Overview
  • ARIES - Tuberculosis Assay
  • ARIES - Tuberculosis Assay Product Overview
  • ARIES Flu A/B/RSV/SARS-CoV-2 Assay
  • ARIES Flu A/B/RSV/SARS-CoV-2 Assay Product Overview
  • Aries LDT Cartridge
  • Aries LDT Cartridge Product Overview
  • ARIES V2
  • ARIES V2 Product Overview
  • ATLAS System - Enteric Assay
  • ATLAS System - Enteric Assay Product Overview
  • Companion Diagnostic Device - Alzheimer's Disease
  • Companion Diagnostic Device - Alzheimer's Disease Product Overview
  • Diagnostic Assay - MRSA
  • Diagnostic Assay - MRSA Product Overview
  • Diagnostic Assay - RVP II
  • Diagnostic Assay - RVP II Product Overview
  • Fungal Panel Assay
  • Fungal Panel Assay Product Overview
  • Guava Next Gen
  • Guava Next Gen Product Overview
  • LX200/FM3D Convalescent Serum - COVID-19
  • LX200/FM3D Convalescent Serum - COVID-19 Product Overview
  • LX200/FM3D Immunity Status - COVID-19
  • LX200/FM3D Immunity Status - COVID-19 Product Overview
  • MAGPIX - Ebola Virus Assay
  • MAGPIX - Ebola Virus Assay Product Overview
  • MAGPIX Convalescent Serum - COVID-19
  • MAGPIX Convalescent Serum - COVID-19 Product Overview
  • MAGPIX Serology Immunity Status - COVID-19
  • MAGPIX Serology Immunity Status - COVID-19 Product Overview
  • MAGPIX Syndromic Dx - COVID-19
  • MAGPIX Syndromic Dx - COVID-19 Product Overview
  • Meningitis Panel Assay
  • Meningitis Panel Assay Product Overview
  • NxTAG Respiratory Pathogen Panel - Expanded Version
  • NxTAG Respiratory Pathogen Panel - Expanded Version Product Overview
  • Portable Field Deployed Diagnostic Tool
  • Portable Field Deployed Diagnostic Tool Product Overview
  • VERIGENE I Acute Dx - COVID-19
  • VERIGENE I Acute Dx - COVID-19 Product Overview
  • VERIGENE I SARS-CoV-2
  • VERIGENE I SARS-CoV-2 Product Overview
  • VERIGENE II Acute Dx - COVID-19
  • VERIGENE II Acute Dx - COVID-19 Product Overview
  • VERIGENE II Gastrointestinal Flex Assay
  • VERIGENE II Gastrointestinal Flex Assay Product Overview
  • VERIGENE II Gastrointestinal Flex Assay Clinical Trial
  • VERIGENE II Respiratory Flex Assay
  • VERIGENE II Respiratory Flex Assay Product Overview
  • VERIGENE II SARS-CoV-2
  • VERIGENE II SARS-CoV-2 Product Overview
  • VERIGENE II Syndromic Dx - COVID-19
  • VERIGENE II Syndromic Dx - COVID-19 Product Overview
  • Verigene II System
  • Verigene II System Product Overview
  • Verigene II System - Blood Culture ID Assay
  • Verigene II System - Blood Culture ID Assay Product Overview
  • Verigene II System - Meningitis Panel
  • Verigene II System - Meningitis Panel Product Overview
  • Verigene II System - Syndromic Assay
  • Verigene II System - Syndromic Assay Product Overview
  • xMAP-Powered Assay - Breast Cancer
  • xMAP-Powered Assay - Breast Cancer Product Overview
Luminex Corp - Key Competitors

Luminex Corp - Key Employees
  • Luminex Corp - Key Employee Biographies
Luminex Corp - Locations and Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • Luminex Corp, Recent Developments
  • Mar 09, 2021: Luminex to Participate at the 2021 Barclays Global Healthcare Conference
  • Oct 07, 2020: For COVID-19 detection and epidemiology, xMAP technology offers unique advantages
  • Mar 31, 2020: AdvaMed: COVID-19 test availability rapidly scales up
  • Mar 04, 2020: Luminex provides updates on critical efforts related to novel coronavirus
  • Feb 24, 2020: Luminex submits VERIGENE II Respiratory Flex Assay for FDA clearance
  • Feb 10, 2020: Luminex reports fourth quarter and full-year 2019 results
  • Jan 23, 2020: Luminex To Release Fourth Quarter and Full-Year 2019 Results After Market Close On February 10, 2020
  • Nov 04, 2019: Luminex Corporation reports third quarter 2019 results and submission of VERIGENE II Gastrointestinal Flex Assay to the FDA
  • Nov 04, 2019: Luminex reports third quarter 2019 results and submission of VERIGENE II Gastrointestinal Flex Assay to the FDA
  • Jul 31, 2019: Luminex reports second quarter 2019 financial results and increase in quarterly dividend
Appendix
  • Methodology
  • About the Publisher
List of Tables
  • Luminex Corp Pipeline Products and Ongoing Clinical Trials Overview
  • Luminex Corp Pipeline Products by Equipment Type
  • Luminex Corp Pipeline Products by Indication
  • Luminex Corp Ongoing Clinical Trials by Trial Status
  • Luminex Corp, Key Facts
  • Luminex Corp, Major Products and Services
  • Luminex Corp Number of Pipeline Products by Development Stage
  • Luminex Corp Pipeline Products Summary by Development Stage
  • Luminex Corp Ongoing Clinical Trials by Trial Status
  • Luminex Corp Ongoing Clinical Trials Summary
  • ARIES - Tuberculosis Assay - Product Status
  • ARIES - Tuberculosis Assay - Product Description
  • ARIES Flu A/B/RSV/SARS-CoV-2 Assay - Product Status
  • ARIES Flu A/B/RSV/SARS-CoV-2 Assay - Product Description
  • Aries LDT Cartridge - Product Status
  • Aries LDT Cartridge - Product Description
  • ARIES V2 - Product Status
  • ARIES V2 - Product Description
  • ATLAS System - Enteric Assay - Product Status
  • ATLAS System - Enteric Assay - Product Description
  • Companion Diagnostic Device - Alzheimer's Disease - Product Status
  • Companion Diagnostic Device - Alzheimer's Disease - Product Description
  • Diagnostic Assay - MRSA - Product Status
  • Diagnostic Assay - MRSA - Product Description
  • Diagnostic Assay - RVP II - Product Status
  • Diagnostic Assay - RVP II - Product Description
  • Fungal Panel Assay - Product Status
  • Fungal Panel Assay - Product Description
  • Guava Next Gen - Product Status
  • Guava Next Gen - Product Description
  • LX200/FM3D Convalescent Serum - COVID-19 - Product Status
  • LX200/FM3D Convalescent Serum - COVID-19 - Product Description
  • LX200/FM3D Immunity Status - COVID-19 - Product Status
  • LX200/FM3D Immunity Status - COVID-19 - Product Description
  • MAGPIX - Ebola Virus Assay - Product Status
  • MAGPIX - Ebola Virus Assay - Product Description
  • MAGPIX Convalescent Serum - COVID-19 - Product Status
  • MAGPIX Convalescent Serum - COVID-19 - Product Description
  • MAGPIX Serology Immunity Status - COVID-19 - Product Status
  • MAGPIX Serology Immunity Status - COVID-19 - Product Description
  • MAGPIX Syndromic Dx - COVID-19 - Product Status
  • MAGPIX Syndromic Dx - COVID-19 - Product Description
  • Meningitis Panel Assay - Product Status
  • Meningitis Panel Assay - Product Description
  • NxTAG Respiratory Pathogen Panel - Expanded Version - Product Status
  • NxTAG Respiratory Pathogen Panel - Expanded Version - Product Description
  • Portable Field Deployed Diagnostic Tool - Product Status
  • Portable Field Deployed Diagnostic Tool - Product Description
  • VERIGENE I Acute Dx - COVID-19 - Product Status
  • VERIGENE I Acute Dx - COVID-19 - Product Description
  • VERIGENE I SARS-CoV-2 - Product Status
  • VERIGENE I SARS-CoV-2 - Product Description
  • VERIGENE II Acute Dx - COVID-19 - Product Status
  • VERIGENE II Acute Dx - COVID-19 - Product Description
  • VERIGENE II Gastrointestinal Flex Assay - Product Status
  • VERIGENE II Gastrointestinal Flex Assay - Product Description
  • VERIGENE II Gastrointestinal Flex Assay - A Clinical Study of Gastrointestinal (GI) Assay on VERIGENE II System in the Detection of Gastrointestinal Infections
  • VERIGENE II Respiratory Flex Assay - Product Status
  • VERIGENE II Respiratory Flex Assay - Product Description
  • VERIGENE II SARS-CoV-2 - Product Status
  • VERIGENE II SARS-CoV-2 - Product Description
  • VERIGENE II Syndromic Dx - COVID-19 - Product Status
  • VERIGENE II Syndromic Dx - COVID-19 - Product Description
  • Verigene II System - Product Status
  • Verigene II System - Product Description
  • Verigene II System - Blood Culture ID Assay - Product Status
  • Verigene II System - Blood Culture ID Assay - Product Description
  • Verigene II System - Meningitis Panel - Product Status
  • Verigene II System - Meningitis Panel - Product Description
  • Verigene II System - Syndromic Assay - Product Status
  • Verigene II System - Syndromic Assay - Product Description
  • xMAP-Powered Assay - Breast Cancer - Product Status
  • xMAP-Powered Assay - Breast Cancer - Product Description
Luminex Corp, Key Employees
  • Luminex Corp, Key Employee Biographies
  • Luminex Corp, Other Locations
  • Luminex Corp, Subsidiaries
  • Glossary
List of Figures
  • Luminex Corp Pipeline Products by Equipment Type
  • Luminex Corp Pipeline Products by Development Stage
  • Luminex Corp Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • T2 Biosystems Inc
  • Siemens Medical Solutions USA Inc
  • Roche Diagnostics International Ltd
  • Quidel Corp
  • Quanterix Corp
  • Qiagen NV
  • PerkinElmer Inc
  • Meso Scale Diagnostics LLC
  • Meridian Bioscience Inc
  • Life Technologies Corp
  • Illumina Inc
  • Hologic Inc
  • Focus Diagnostics Inc
  • Cytek Biosciences Inc
  • Cepheid Inc
  • Bio-Rad Laboratories Inc
  • BioFire Diagnostics Inc
  • Becton Dickinson and Co
  • Alere Inc
  • Affymetrix, Inc.
  • ACEA Biosciences Inc
  • Accelerate Diagnostics Inc
Note: Product cover images may vary from those shown
Adroll
adroll